A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 119.00
GOOG 540.37
MSFT 47.75
FB 77.62
BAC 17.11

Recently Added

EVC 6.32
SPG 180.69
R 93.98
SKX 60.38
CTRE 16.09

Gaining Speed

EVC 6.32
TMO 128.66
BABA 112.67
SPN 23.38
FB 77.62

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More

Get Alerted When News Hits On This Stock - FREE!